Precision Imaging to Evaluate Kaposi Sarcoma

Last updated: May 7, 2026
Sponsor: Washington University School of Medicine
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Sarcoma

Kaposi's Sarcoma

Soft Tissue Sarcoma

Treatment

SkinScan3D

Clinical Study ID

NCT06898203
202604055
U01CA292765
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

AIMS 2 & 3:

In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.

Eligibility Criteria

Inclusion

Inclusion Criteria - Aim 2 (Patients):

  • Adults age ≥18 years old

  • Histopathology-confirmed Kaposi Sarcoma

  • At least 3 skin lesions

  • Capable of informed consent

  • On treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 2 (Patients):

  • Patients not initiating Kaposi Sarcoma treatment

  • Very ill patients requiring hospitalization

Inclusion Criteria - Aim 3 (Patients):

  • Adults age ≥18 years old

  • Histopathology-confirmed Kaposi Sarcoma

  • Capable of informed consent

  • Initiating treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 3 (Patients):

  • Patients with Kaposi Sarcoma that participated in Aim 1 or Aim 2

  • Prior or ongoing Kaposi Sarcoma treatment

Study Design

Total Participants: 300
Treatment Group(s): 1
Primary Treatment: SkinScan3D
Phase:
Study Start date:
May 31, 2026
Estimated Completion Date:
November 30, 2029

Connect with a study center

  • Kenya Medical Research Institute

    Kisumu,
    Kenya

    Site Not Available

  • Infectious Diseases Institute, Makerere University

    Kampala,
    Uganda

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.